BioBridge Global
BioBridge Global is a nonprofit organization dedicated to saving and enhancing lives through the healing power of human cells and tissue. It operates a family of nonprofits including South Texas Blood & Tissue, QualTex Laboratories, GenCure, and The Blood & Tissue Center Foundation. The organization provides lifesaving therapies to patients and supports advances in advanced therapies, focusing on blood, cell, and tissue products, testing services, and the development of new therapies.
Industries
N/A
Nr. of Employees
small (1-50)
BioBridge Global
6211 IH 10 West San Antonio, Texas 78201
Awards
Regenerative Medicine (REGEN) RPP
Commercial Scale Up of Bone Marrow-Derived Mesenchymal Stem Cells for Regenerative Medicine
Funding (ceiling)
$6,740,031.41
Award Year
2016
Products
Blood components for transfusion
Clinical blood products including red blood cells, platelets, plasma and cryoprecipitate for hospital transfusion use.
Leukopaks and apheresis-derived starting materials
Autologous and allogeneic leukopaks and other apheresis collections provided fresh or cryopreserved with specified cell counts for downstream manufacturing.
Cord blood units (fresh or frozen)
Cord blood units collected, characterized and cryopreserved for transplant or research with unit selection by total nucleated cell count, volume or RBC content.
Perinatal and birth tissue products
Fresh or frozen perinatal tissues (umbilical cord, placenta, birth tissue) recovered, tested and provided for research or processing by tissue processors.
Cryopreserved grafts and tissue storage
Autologous tissue storage and provision of cryopreserved grafts for clinical surgical use (cardiac, vascular and other graft types).
Biomaterials and research-grade biospecimens
Access to research-grade biomaterials including PBMCs, whole blood derivatives, buffy coats and deceased donor tissues for research use.
Blood components for transfusion
Clinical blood products including red blood cells, platelets, plasma and cryoprecipitate for hospital transfusion use.
Leukopaks and apheresis-derived starting materials
Autologous and allogeneic leukopaks and other apheresis collections provided fresh or cryopreserved with specified cell counts for downstream manufacturing.
Cord blood units (fresh or frozen)
Cord blood units collected, characterized and cryopreserved for transplant or research with unit selection by total nucleated cell count, volume or RBC content.
Perinatal and birth tissue products
Fresh or frozen perinatal tissues (umbilical cord, placenta, birth tissue) recovered, tested and provided for research or processing by tissue processors.
Cryopreserved grafts and tissue storage
Autologous tissue storage and provision of cryopreserved grafts for clinical surgical use (cardiac, vascular and other graft types).
Biomaterials and research-grade biospecimens
Access to research-grade biomaterials including PBMCs, whole blood derivatives, buffy coats and deceased donor tissues for research use.
Expertise Areas
- Blood collection and transfusion services
- Apheresis collections for cell therapy starting materials
- cGMP biomanufacturing and IND-phase support for cell therapies
- Analytical assay development, qualification and transfer to cGMP
Key Technologies
- Flow cytometry (multi-parameter panels)
- qPCR / nucleic acid testing (viral panels)
- Multiplex cytokine assays
- ELISA and immunoassays
Key People
CEO, BioBridge Global
Senior Vice President, Chief Medical Officer
Senior Vice President, Talent & Performance Management
Senior Vice President, BioBridge Global and Chief Operating Officer, QualTex Laboratories and GenCure
Senior Vice President and Chief Scientific Officer, BioBridge Global
Senior Vice President, BioBridge Global and Chief Operating Officer, South Texas Blood & Tissue
CEO, BioBridge Global
Senior Vice President, Chief Medical Officer
Senior Vice President, Talent & Performance Management
Senior Vice President, BioBridge Global and Chief Operating Officer, QualTex Laboratories and GenCure
Senior Vice President and Chief Scientific Officer, BioBridge Global
Senior Vice President, BioBridge Global and Chief Operating Officer, South Texas Blood & Tissue
News & Updates
On Jan. 2, 2023, Asante Contreras and 43 other donors across the nation were honored for their contributions.
BioBridge Global’s R&D Analytical Development team now has a specialized lab to call their own.
BioBridge Global CEO Martin Landon spoke on a panel during the Invest San Antonio 2023-2024 Conference, highlighting the organization's growing capabilities.
South Texas Blood & Tissue leaders were featured in a webinar on an innovative program to collect whole blood-derived platelets.
On Jan. 2, 2023, Asante Contreras and 43 other donors across the nation were honored for their contributions.
BioBridge Global’s R&D Analytical Development team now has a specialized lab to call their own.
BioBridge Global CEO Martin Landon spoke on a panel during the Invest San Antonio 2023-2024 Conference, highlighting the organization's growing capabilities.
South Texas Blood & Tissue leaders were featured in a webinar on an innovative program to collect whole blood-derived platelets.